News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,310 Results
Type
Article (85694)
Company Profile (747)
Press Release (746869)
Section
Business (232291)
Career Advice (4108)
Deals (39653)
Drug Delivery (120)
Drug Development (90705)
Employer Resources (194)
FDA (17988)
Job Trends (17275)
News (395669)
Policy (39630)
Tag
Academia (2975)
Alliances (56518)
Alzheimer's disease (1356)
Approvals (17897)
Artificial intelligence (177)
Bankruptcy (394)
Best Places to Work (12549)
Biotechnology (512)
Breast cancer (174)
Cancer (1377)
Cardiovascular disease (120)
Career advice (3514)
Cell therapy (308)
Clinical research (71855)
Collaboration (479)
Compensation (253)
COVID-19 (2810)
C-suite (119)
Data (1377)
Diabetes (177)
Diagnostics (6710)
Earnings (94798)
Employer resources (167)
Events (127247)
Executive appointments (371)
FDA (18642)
Funding (430)
Gene therapy (219)
GLP-1 (710)
Government (5052)
Healthcare (20735)
Infectious disease (2907)
Inflammatory bowel disease (124)
Interviews (807)
IPO (17617)
Job creations (5180)
Job search strategy (2855)
Layoffs (492)
Legal (10048)
Lung cancer (204)
Manufacturing (222)
Medical device (14446)
Medtech (14451)
Mergers & acquisitions (22128)
Metabolic disorders (498)
Neuroscience (1702)
NextGen Class of 2024 (7658)
Non-profit (5067)
Northern California (1664)
Obesity (287)
Opinion (245)
Patents (123)
People (64292)
Pharmaceutical (152)
Phase I (22131)
Phase II (31201)
Phase III (23525)
Pipeline (512)
Postmarket research (3547)
Preclinical (10000)
Radiopharmaceuticals (259)
Rare diseases (276)
Real estate (7373)
Regulatory (26060)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1457)
Startups (4276)
United States (15751)
Vaccines (663)
Weight loss (228)
Date
Today (152)
Last 7 days (670)
Last 30 days (3108)
Last 365 days (38283)
2024 (36976)
2023 (42568)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (229)
Asia (49445)
Australia (8711)
California (3855)
Canada (1407)
China (303)
Colorado (176)
Connecticut (190)
Europe (113243)
Florida (519)
Georgia (138)
Illinois (444)
Indiana (234)
Maryland (668)
Massachusetts (3100)
Michigan (187)
Minnesota (309)
New Jersey (1104)
New York (1081)
North Carolina (870)
Northern California (1664)
Ohio (154)
Pennsylvania (920)
South America (1647)
Southern California (1457)
Texas (566)
Utah (110)
Washington State (425)
There are 833,310 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Acelyrin Terminates Izokibep After Failed Phase IIb/III Uveitis Data
The discontinuation caps off a turbulent development path for izokibep, which in September 2023 produced disappointing results from Phase IIb/III study in hidradenitis suppurativa that was found to have had dosing errors.
December 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Gastroenterology Market Projected to Reach USD 53.10 Billion by 2031, Says Coherent Market Insights
December 11, 2024
·
1 min read
Press Releases
Gene Therapy Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Genetic Disorders
December 11, 2024
·
1 min read
IPO
After Making the IPO Jump, Biotechs Landed On a Slippery Slope
Around 25 companies have gone public this year, most of them in the early months. Most have tumbled from their original offer price.
December 11, 2024
·
1 min read
·
Annalee Armstrong
Mergers & Acquisitions
Pharma Has Kept M&A Spending Small This Year, With Just One Deal Topping $5B
By far, the largest acquisition of 2024 was Novo Holdings’ yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion. Outside of that, the leading pharmaceutical companies kept to less than $5 billion per deal.
December 11, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
LadRx Planning NDA Submission under 505(b)(2) for Aldoxorubicin and Other Updates
December 11, 2024
·
1 min read
Press Releases
Medical Second Opinion Market Projected to Worth USD 20.45 Billion by 2031, Says Coherent Market Insights
December 11, 2024
·
1 min read
Press Releases
Medical Device Contract Manufacturing Market Size to Outpace US$ 192.3 Billion by 2030, Says Coherent Market Insights Inc.
December 11, 2024
·
1 min read
Layoff Tracker
Cellectar Downsizes by 60% as it Explores Strategic Options for Cancer Drug
Follow along as
BioSpace
keeps you up-to-date on the latest pharma and biotech layoffs.
December 11, 2024
·
202 min read
·
BioSpace Editorial Staff
Press Releases
Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)
December 11, 2024
·
2 min read
1 of 83,331
Next
